Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nichola Cooper

Showing results (51-60 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantationJulio Delgado, Nichola Cooper, Kirsty Thomson, et al.
Journal of Market Access & Health Policy|April 25, 2025
The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UKNichola Cooper, Sebastian Guterres, Michał Pochopień, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
Blood|March 6, 2002
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?Nichola Cooper, B Michael R Woloski, Erin M Fodero, et al.
Blood Advances|January 14, 2025
The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopeniaNehal Joshi, Hana Lango-Allen, Kate Downes, et al.
Blood Advances|April 12, 2022
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopeniaJohn Grainger, James Bussel, Michael Tarantino, et al.
Blood|October 13, 2005
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosisNichola Cooper, Kanchan Rao, Kimberly Gilmour, et al.
Blood|September 3, 2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelatorEvangelia Vlachodimitropoulou, Yu-Lin Chen, Maciej Garbowski, et al.
The Patient|August 16, 2025
A Qualitative Study on Patient Experience with Signs, Symptoms, and Daily Impacts of Immune ThrombocytopeniaWaleed Ghanima, Nichola Cooper, Sylvie Bozzi, et al.
Pageof 15

Showing results (51-60 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|September 26, 2022
Romiplostim use in pregnant women with immune thrombocytopeniaJames B Bussel, Nichola Cooper, Tatiana Lawrence, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantationJulio Delgado, Nichola Cooper, Kirsty Thomson, et al.
Journal of Market Access & Health Policy|April 25, 2025
The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UKNichola Cooper, Sebastian Guterres, Michał Pochopień, et al.
British Journal of Haematology|April 3, 2004
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpuraNichola Cooper, Roberto Stasi, Susanna Cunningham-Rundles, et al.
Blood|March 6, 2002
Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?Nichola Cooper, B Michael R Woloski, Erin M Fodero, et al.
Blood Advances|January 14, 2025
The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopeniaNehal Joshi, Hana Lango-Allen, Kate Downes, et al.
Blood Advances|April 12, 2022
A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopeniaJohn Grainger, James Bussel, Michael Tarantino, et al.
Blood|October 13, 2005
Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosisNichola Cooper, Kanchan Rao, Kimberly Gilmour, et al.
Blood|September 3, 2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelatorEvangelia Vlachodimitropoulou, Yu-Lin Chen, Maciej Garbowski, et al.
The Patient|August 16, 2025
A Qualitative Study on Patient Experience with Signs, Symptoms, and Daily Impacts of Immune ThrombocytopeniaWaleed Ghanima, Nichola Cooper, Sylvie Bozzi, et al.
Pageof 15